Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Paraoxonase genotype distribution in healthy and CAD population in Croatia (CROSBI ID 479121)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Topić, Elizabeta ; Ivanišević, Ana-Maria ; Štefanović, Mario ; Nikolić, Vjeran ; Petrač, Dubravko ; Čubrilo-Turek, Mirjana Paraoxonase genotype distribution in healthy and CAD population in Croatia // Cardiovascular Genomics / Ghatak, Carol A. ; Diomede, Kristina (ur.). Orlando (FL), 1999

Podaci o odgovornosti

Topić, Elizabeta ; Ivanišević, Ana-Maria ; Štefanović, Mario ; Nikolić, Vjeran ; Petrač, Dubravko ; Čubrilo-Turek, Mirjana

engleski

Paraoxonase genotype distribution in healthy and CAD population in Croatia

Paraoxonase (PON), a Ca+2 dependent enzyme, is a high density lipoprotein (HDL) associated esterase hydrolyzing paraoxon. Although the physiologic substrate of PON1 is unknown, a protective role against the oxidative degradation of LDL has been attributed to it. Many studies have suggested that the existence of a genetic polymorphism of PON1 gene involving Gln-to-Arg interchange at position 192 modulates PON activity toward paraoxon. Arg 192 (allele B) is associated with higher activity than Gln 192 (allele A). This polymorphism has been proposed as a genetic marker for the risk of coronary artery disease (CAD). However, data on the relationships between biallelic PON1 polymorphisms at codon 192 (A and B alleles) are very controversial. This study was undertaken to evaluate the frequency of high and low activity phenotypes in a control population of healthy individuals taking no medication, and in a group of patients with coronary artery disease confirmed by angiography. Restriction polymorphism of PON1 A and B alleles was detected on DNA isolated from EDTA blood by the PCR-RFLP method. Leukocyte DNA was isolated by standard phenol/chloroform extraction and ethanol precipitation protocols. A 99 base pair fragment covering the region containing the mutation was amplified by polymerase chain reaction using PCR Core Kit (Roche, Mannheim, Germany), with primers (MWG – Biotech, Ebersberg Germany) described by Humbert et al, in a Progene Thermal Cycler (Techne, Cambridge, England). PCR products were digested with A1W1, separated by agarose gel (3%) electrophoresis and visualized by use of ethidium bromide. Allele A (glutamine) corresponded to a 99 base pare fragment and allele B (arginine) to a 65 and 34 base pair fragment. Results of the study indicated a difference in biallelic polymorphism between the control group and CAD patients as well as the impact of Arg Ž Glu 192 polymorhism in coronary artery disease.

paraoxonase; CAD; PCR-RFLP

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1999.

objavljeno

Podaci o matičnoj publikaciji

Cardiovascular Genomics

Ghatak, Carol A. ; Diomede, Kristina

Orlando (FL):

Podaci o skupu

Cambridge Healthtech Institute's First International Cardiovascular Genomics

poster

11.01.1999-12.01.1999

Orlando (FL), Sjedinjene Američke Države

Povezanost rada

Temeljne medicinske znanosti